Cleared Special

K133474 - BIOSIGN FLU A + B, STATUS FLU A & B (FDA 510(k) Clearance)

Dec 2013
Decision
28d
Days
Class 2
Risk

K133474 is an FDA 510(k) clearance for the BIOSIGN FLU A + B, STATUS FLU A & B. This device is classified as a Devices Detecting Influenza A, B, And C Virus Antigens (Class II - Special Controls, product code PSZ).

Submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on December 10, 2013, 28 days after receiving the submission on November 12, 2013.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3328. An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection..

Submission Details

510(k) Number K133474 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2013
Decision Date December 10, 2013
Days to Decision 28 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PSZ — Devices Detecting Influenza A, B, And C Virus Antigens
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3328
Definition An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection.